XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
XTL Biopharmaceuticals Ltd. has successfully regained compliance with Nasdaq’s minimum bid price requirement, maintaining a closing bid price of at least $1.00 for over 10 consecutive business days. The notice from Nasdaq has formally acknowledged this achievement, thereby closing the matter regarding the company’s previous non-compliance that was identified in October 2023.
For further insights into XTLB stock, check out TipRanks’ Stock Analysis page.
